Allen WL, Johnson JA, Knoell DL, Kolesar JM, McInerney JD, McLeod HL, Spencer HT, Tami JA (Eds). Pharmacogenomics: Applications to Patient Care. American College of Clinical Pharmacy. ACCP, Kansas, MO, 2004.

American Medical Association. Manual of Style. Oxford University Press, New York, 2007.

American Medical Association. USP Dictionary of USAN and International Drugs Names. U.S. Pharmacopeia. Maryland, 2010.

American Society of Health-System Pharmacists (Ed). AHFS Drug Information. 2010. American Society of Health-System Pharmacists (ASHP), Maryland, 2010.

Appasani K (Ed). RNA Interference Technology. From Basic Science to Drug Development. Cambridge University Press, Cambridge, 2005.

Baxter K (Ed). Stockley’s Drug Interactions. Pharmaceutical Press, London, 2010.

Benyunes S (Ed). German Homoeopathic Pharmacopoeia. Medpharm, London, 2009.

Berns K (Ed). Genetic Testing and Molecular Biomarkers. Thomson Reuters, Gainesville, 2011.

Bloom FE, Kupfer DJ. (Eds.). Psychopharmacology: The fourth generation of progress. Raven Press, New York, 1995.

Brenner S, Miller JH (Eds). Encyclopedia of Genetics. Academic Press, San Diego, 2001.

British Medical Association, Royal Pharmaceutical Society of Great Britain (Ed). British National Formulary. BMJ and RPS Publishing Group. Pharmaceutical Press, London, 2011.

British Pharmacopoeia Commission (Ed). British Pharmacopoeia. The Stationery Office, London, 2011.

Cacabelos R (Ed). Molecular Genetics of Alzheimer’s disease and Aging. Methods and Findings in Experimental and Clinical Pharmacology. Prous Science, Barcelona, 2005.

Cacabelos R. Neurogeriatrics Handbook. Alzheimer’s disease and other dementias. Epidemiology and Genetics. Masson, Barcelona, 1999.

Cacabelos R, Tanaka T, Takeda M (Eds). Molecular neurobiology of Alzheimer´s disease and related disorders. Basel, Karger, 2004.

Cavallari LM, Ellingrod VL, Kolesar JM. Lexi-Comp’s Pharmacogenomics Handbook. Lexi-Comp, Inc., Hudson, Ohio, 2005.

Cohen N (Ed). Pharmacogenomics and Personalized Medicine. Humana Press, Totowa, NJ, 2008.

EDQM (Ed). European Pharmacopoeia 7th Edition. Pharmeuropa, Strasbourg, 2011.

Giacobini E. Cholinesterases and cholinesterase inhibitors. Martin Dunitz, London, 2000.

Grieve M. A Modern Herbal. Dover Publications, 1971.

Guidelines for mutation analysis of BCR/ABL kinase domain: Interpreting TKI-Resistance Mutations in CML Patients. West Midlands Regional Genetics Laboratory. 2007.

Guidelines on the Use of INNs for Pharmaceutical Substances (1997). World Health Organization, Geneva, 1997.

Hall IP, Pirmohamed M (Eds). Pharmacogenetics. Informa Healthcare, Taylor & Francis, New York, 2006.

ICD-10-CM Official Guidelines for Coding and Reporting-2010. World Health Organization, Geneva, 2010.

Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development. Rare Diseases and Orphan Products. National Academies Press, Washington (DC), 2010.

International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Version for 2010. World Health Organization, Geneva, 2010.

IPCS Harmonization Project. IPCS Risk Assessment terminology. Part 1:IPCS/OECD Key Generic Terms used in Chemical Hazard/Risk Assessment, Part 2:IPCS Glossary of Key Exposure Assessment Terminology. WHO Document Production Services, Geneva, 2004.

Japanese Pharmacopoeia Commision (Ed). The Japanese Pharmacopoeia. Yakuji Nippo Ltd, Tokio, 2007.

Jellin JM. Natural Medicines Comprehensive Database. Therapeutic Research Faculty. Stockton, 2000.

Kalow W, Meyer U, Tyndale RF (Eds). Pharmacogenomics. Drugs and the Pharmaceutical Sciences. Marcel Dekker, New York, 2001.

King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ (Eds). Virus taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, 2011.

Lacy CF, Armstrong LL, Golman MP, Lance LL (Eds). Lexi-Comp’s Drug Information Handbook. Lexi-Comp, Inc., Hudson, Ohio, 2008-2009.

Lapage SP, Sneath PHA, Lessel EF, SkermanVBD, Seeliger HPR, Clark WA. International Code of Nomenclature of Bacteria. Bacteriological Code, 1990 Revision. ASM Press, Washington (DC), 1992.

Leigh GJ, Favre HA, Metanomski WV. Principles of Chemical Nomenclature: a Guide to IUPAC Recommendations. Blackwell Science, 1998.

Lynch DR (Ed). Neurogenetics. Scientific and Clinical Advances. Taylor & Francis, New York, 2006.

O’Neil M, Smith A, Heckelmann P (Ed). The Merck Index. Merck Publishing, New Jersey, 2006.

Physicians’ Desk Reference. PDR Network, New Jersey, 2011.

PR Vademécum. Kairós, Buenos Aires, 2009.

Price Evans DA (Ed). Genetic factors in drug therapy. Clinical and molecular pharmacognetics. Cambridge University Press, Cambridge, 1993.

Prusiner SB (Ed). Prion biology and diseases. Cold Spring Harbor Laboratory Press, New York, 1999.

Pulst S-M (Ed). Neurogenetics. Oxford University Press, New York, 2000.

Qing Y (Ed). Pharmacogenomics in Drug Discovery and Development. Methods in Molecular Biology. Humana Press, Totowa, NJ, 2008.

Quality Assurance and Safety: Medicines (QSM). WHO Drug Information. World Health Organization, Geneva, 2010.

Rimoin DL, Connor JM, Pyeritz RE, Korf BR (Eds). Emery and Rimoin’s Principles and Practice of Medical Genetics. Churchill Livingstone, Edinburgh, 2002.

Rosemberg RN, DiMauro S, Paulson HL, Ptáček L, Nestler EJ (Eds). The Molecular and Genetic Basis of Neurologic and Psychiatric Disease. Wolters Kluver/Lippincott Williams & Wilkins, Philadelphia, 2008.

Scriver CR, Beaudet AL, Sly WS, Valle MD (Eds). The Metabolic & Molecular Bases of Inherited Disease. McGraw-Hill, New York, 2001.

Sweetman S (Ed). Martindale: The Complete Drug Reference. Pharmaceutical Press, London, 2010.

Swiss Pharmaceutical Society (Ed). Index Nominum. International Drug Directory. MedPharm, Bern, 2010.

United States Pharmacopeia Convention. The United States Pharmacopoeia 34 – National Formulary 29 (USP 34-NF 29). USP, Maryland, 2011.

Vademécum Internacional. UBM Medica, Madrid, 2011.

WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs, 2011. Oslo, 2010.

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2011. Oslo, 2010.

WHO Department of Essential Medicines and Pharmaceutical Policies (EMP). The International Pharmacopoeia Fourth Edition 2011 (incl. First and Second Supplements). 2011.

Wynn GH, Oesterheld JR, Cozza KL, Armstrong SC (Ed). Manual of Drug Interaction Principles for Medical Practice: The P450 System. American Psychiatric Publishing Inc, Arlington, 2009.